Sign in
4

Changes in Ownership

Caribou Biosciences, Inc. Filed Acc 0001209191-21-070804

Options or other derivatives

  • President and CEO acquired 411,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Haurwitz Rachel E. · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-12-20 Grant or award : show line 1 in the form Option to purchase Common Stock +411,000 411,000 D
Loading xslF345X03/doc4.xml…